Mary Walton

515 total citations
19 papers, 407 citations indexed

About

Mary Walton is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mary Walton has authored 19 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mary Walton's work include Viral Infections and Immunology Research (7 papers), HIV/AIDS Research and Interventions (4 papers) and Digital Mental Health Interventions (4 papers). Mary Walton is often cited by papers focused on Viral Infections and Immunology Research (7 papers), HIV/AIDS Research and Interventions (4 papers) and Digital Mental Health Interventions (4 papers). Mary Walton collaborates with scholars based in United States. Mary Walton's co-authors include Frederick L. Altice, R. Douglas Bruce, Joseph L. Melnick, Sandra A. Springer, Adrian Marinovich, Duncan Maru, Gerald Friedland, J. L. Hodges, Peter Isacson and Duncan Smith-Rohrberg and has published in prestigious journals such as The Journal of Experimental Medicine, Clinical Infectious Diseases and American Journal of Epidemiology.

In The Last Decade

Mary Walton

18 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Walton United States 11 275 230 62 61 59 19 407
Jean‐Jacques Cheseaux Switzerland 9 189 0.7× 194 0.8× 68 1.1× 25 0.4× 51 0.9× 18 455
Monica M. F. Magnanini Brazil 8 513 1.9× 419 1.8× 93 1.5× 20 0.3× 151 2.6× 10 616
Félix Omeñaca Teres Spain 6 193 0.7× 139 0.6× 61 1.0× 6 0.1× 112 1.9× 12 331
Heloísa Ramos Lacerda Brazil 13 269 1.0× 145 0.6× 27 0.4× 10 0.2× 128 2.2× 42 414
Fizza S. Gillani United States 15 429 1.6× 318 1.4× 77 1.2× 7 0.1× 99 1.7× 51 556
Adauto Castelo Brazil 11 93 0.3× 168 0.7× 70 1.1× 21 0.3× 17 0.3× 19 405
Steven Y. Hong United States 14 527 1.9× 223 1.0× 151 2.4× 22 0.4× 244 4.1× 34 675
Sufia Dadabhai United States 10 285 1.0× 229 1.0× 157 2.5× 10 0.2× 44 0.7× 42 440
W. William Schluter United States 13 164 0.6× 195 0.8× 38 0.6× 47 0.8× 9 0.2× 26 436
Jesús Íñigo Martínez Spain 11 203 0.7× 246 1.1× 16 0.3× 27 0.4× 27 0.5× 30 365

Countries citing papers authored by Mary Walton

Since Specialization
Citations

This map shows the geographic impact of Mary Walton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Walton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Walton more than expected).

Fields of papers citing papers by Mary Walton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Walton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Walton. The network helps show where Mary Walton may publish in the future.

Co-authorship network of co-authors of Mary Walton

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Walton. A scholar is included among the top collaborators of Mary Walton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Walton. Mary Walton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Walton, Mary, et al.. (2024). Old tech but not low tech: telephone-based treatment provision for substance use. Frontiers in Psychiatry. 15. 1351816–1351816.
2.
Kang, Augustine, et al.. (2022). Barriers and poor telephone counseling experiences among patients receiving medication for opioid use disorders. Patient Education and Counseling. 105(7). 2607–2610. 7 indexed citations
3.
Kang, Augustine, et al.. (2021). Patient Experiences with the Transition to Telephone Counseling during the COVID-19 Pandemic. Healthcare. 9(6). 663–663. 7 indexed citations
4.
Martin, Rosemarie A., et al.. (2021). Medication for Opioid Use Disorder Service Provision and Telephone Counseling: A Concurrent Mixed-Methods Approach. International Journal of Environmental Research and Public Health. 18(11). 6163–6163. 7 indexed citations
5.
Walton, Mary, et al.. (2021). Clinical Pearls for Buprenorphine Treatment. 11(1). 1–10. 1 indexed citations
6.
Gibson, Britton A., Jamie P. Morano, Mary Walton, et al.. (2017). Innovative Program Delivery and Determinants of Frequent Visitation to a Mobile Medical Clinic in an Urban Setting. Journal of Health Care for the Poor and Underserved. 28(2). 643–662. 17 indexed citations
7.
Morano, Jamie P., Alexei Zelenev, Mary Walton, R. Douglas Bruce, & Frederick L. Altice. (2014). Latent Tuberculosis Infection Screening in Foreign-Born Populations: A Successful Mobile Clinic Outreach Model. American Journal of Public Health. 104(8). 1508–1515. 20 indexed citations
8.
Morano, Jamie P., Mary Walton, Alexei Zelenev, R. Douglas Bruce, & Frederick L. Altice. (2013). Latent Tuberculosis Infection: Screening and Treatment in an Urban Setting. Journal of Community Health. 38(5). 941–950. 14 indexed citations
9.
Maru, Duncan, R. Douglas Bruce, Mary Walton, Sandra A. Springer, & Frederick L. Altice. (2009). Persistence of Virological Benefits Following Directly Administered Antiretroviral Therapy Among Drug Users: Results From a Randomized Controlled Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(2). 176–181. 37 indexed citations
10.
Maru, Duncan, et al.. (2007). Initiation, Adherence, and Retention in a Randomized Controlled Trial of Directly Administered Antiretroviral Therapy. AIDS and Behavior. 12(2). 284–293. 33 indexed citations
11.
Smith-Rohrberg, Duncan, et al.. (2006). Impact of Enhanced Services on Virologic Outcomes in a Directly Administered Antiretroviral Therapy Trial for HIV-Infected Drug Users. JAIDS Journal of Acquired Immune Deficiency Syndromes. 43(Supplement 1). S48–S53. 53 indexed citations
12.
Altice, Frederick L., J. L. Hodges, R. Douglas Bruce, et al.. (2004). Developing a Directly Administered Antiretroviral Therapy Intervention for HIV-Infected Drug Users: Implications for Program Replication. Clinical Infectious Diseases. 38(Supplement_5). S376–S387. 94 indexed citations
13.
Melnick, Joseph L., et al.. (1957). ENVIRONMENTAL STUDIES OP ENDEMIC ENTERIC VIRUS INFECTIONS: I. COMMUNITY SEROIMMUNE PATTERNS AND POLIOVIRUS INFECTION RATES12. American Journal of Epidemiology. 65(1). 1–28. 18 indexed citations
14.
Isacson, Peter, et al.. (1957). ENVIRONMENTAL STUDIES OP ENDEMIC ENTERIC VIRUS INFECTIONS: II. POLIOVIRUS INFECTIONS IN HOUSEHOLD UNITS12. American Journal of Epidemiology. 65(1). 29–42. 7 indexed citations
15.
Melnick, Joseph L., et al.. (1956). AN ENDEMIOLOGICAL STUDY OF ENTERIC VIRUS INFECTIONS. The Journal of Experimental Medicine. 103(2). 247–262. 47 indexed citations
16.
Walton, Mary & Joseph L. Melnick. (1955). Poliomyelitis antibodies in two differing socioeconomic groups within the same city.. PubMed. 27(5). 350–70. 14 indexed citations
17.
Melnick, Joseph L., John R. Paul, & Mary Walton. (1955). Serologic Epidemiology of Poliomyelitis. American Journal of Public Health and the Nations Health. 45(4). 429–437. 18 indexed citations
18.
Melnick, Joseph L., et al.. (1953). Isolation of a Coxsackie Virus during a Summer Outbreak of Acute Minor Illness. Public Health Reports (1896-1970). 68(12). 1178–1178. 7 indexed citations
19.
Walton, Mary & Joseph L. Melnick. (1953). Coxsackie Virus Antibody and Incidence of Minor Illness during the Summer. Public Health Reports (1896-1970). 68(12). 1167–1167. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Jacques Cheseaux Breakdown of academic impact, for papers by Monica M. F. Magnanini Breakdown of academic impact, for papers by Félix Omeñaca Teres Breakdown of academic impact, for papers by Heloísa Ramos Lacerda Breakdown of academic impact, for papers by Fizza S. Gillani Breakdown of academic impact, for papers by Adauto Castelo Breakdown of academic impact, for papers by Steven Y. Hong Breakdown of academic impact, for papers by Sufia Dadabhai Breakdown of academic impact, for papers by W. William Schluter Breakdown of academic impact, for papers by Jesús Íñigo Martínez
Rankless by CCL
2026